Proposed LCDs

When there are Proposed Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Proposed under development, not yet released for comment
C = Proposed LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Proposed LCD Comments to:

Mail:
Noridian Medicare JE Part B
Attention: Proposed LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

 
Proposed LCD and Billing and Coding Article Title Release Date of Proposed LCD for Comment End Date for Comment Period Current Status Comments / Responses Date of Release for Notice Link to Final LCD
Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)

Billing and Coding: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)		 05/30/2024 07/13/2024 F View 10/24/2024 View
Botulinum Toxin Injections

Billing and Coding: Botulinum Toxin Injections		 05/30/2024 07/13/2024 E  
Intervertebral Disc Repair

Billing and Coding: Intervertebral Disc Repair		 08/29/24 10/12/24 E      
Micro-Invasive Glaucoma Surgery (MIGS)

Billing and Coding: Micro-Invasive Glaucoma Surgery 		05/30/2024 07/13/2024 F View 09/27/24 View

Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)

Billing and Coding: Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)

 03/28/24 05/11/24 E  
Polysomnography and Other Sleep Studies

Billing and Coding: Polysomnography and Other Sleep Studies		 07/18/24 09/01/24 C  
Skin Substitutes Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

Billing and Coding: Skin Substitutes Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers		 04/25/24 06/08/2024 F View 11/14/24 View
Urine Drug Testing 09/19/24 11/02/24 C  
Last Updated Dec 11 , 2024